Kazunori Imada
Mochida Pharmaceutical (Japan)(JP)Kyoto University(JP)Osaka Hospital(JP)Osaka Red Cross Hospital(JP)
Publications by Year
Research Areas
T-cell and Retrovirus Studies, Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Vector-Borne Animal Diseases
Most-Cited Works
- → The Jak-STAT pathway(2000)606 cited
- → Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity(1998)320 cited
- → The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.(1996)307 cited
- → An Indirect Effect of Stat5a in IL-2–Induced Proliferation: A Critical Role for Stat5a in IL-2–Mediated IL-2 Receptor α Chain Induction(1997)273 cited
- → Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study(2015)257 cited
- → Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma(2010)243 cited